AbbVie Inc.

    ABBV ·NYSE ·Pharmaceutical Preparations ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-05-09 10-Q expected by 2026-05-14 (in 8 days)
    • ~2026-08-04 10-Q expected by 2026-08-09 (in 95 days)
    • ~2026-11-04 10-Q expected by 2026-11-09 (in 187 days)
    • ~2027-02-19 10-K expected by 2027-03-03 (in 294 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-29 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-04-03 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-03-04 8-K Other Events; Financial Statements and Exhibits
    • 2026-02-26 8-K Other Events; Financial Statements and Exhibits
    • 2026-02-20 10-K Annual Report
    • 2026-02-04 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-07 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-11-04 10-Q Quarterly Report
    • 2025-10-31 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-10-03 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-08-04 10-Q Quarterly Report
    • 2025-07-31 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-07-03 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-13 8-K Officer/Director Change; Shareholder Vote Results
    • 2025-05-09 10-Q Quarterly Report